Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit

Kamada

23/11/2022 21:15

Nov 23 (Reuters) - AcuCort AB  ACUC.TE :
    * ACUCORT SIGNS ITS FIRST COMMERCIAL AGREEMENT FOR THE
COMPANY'S
DRUG ZEQMELIT™
    * ACUCORT AB - KAMADA'S ASSESSMENT IS THAT CO WILL BE ABLE
TO
APPLY FOR REGISTRATION AND MARKET APPROVAL TO ISRAELI AUTHORITY
MOH IN Q1 OF 2023
    * ACUCORT AB - AGREEMENT GIVES KAMADA EXCLUSIVE RIGHT TO
MARKETING
AND SALES AS WELL AS DISTRIBUTION OF ZEQMELIT IN ISRAELI MARKET

Source text for Eikon:  ID:nPreFRXYPa 
Further company coverage:  ACUC.TE 
 ((Reuters.Briefs@thomsonreuters.com;))